STING1 and lung carcinoma: Studies show that STING (stimulator of interferon genes) agonists can activate NLRP3 by the caspase-1 pathway, thereby promoting the occurrence of pyroptosis and inhibit tumor progression in the Lewis mouse lung cancer model with neoantigen (37, 38).